Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Hematology
•
General Rheumatology
•
Dermatology
•
Pediatric Rheumatology
What is your approach to treatment in patients with cutaneous mastocytosis and inflammatory arthritis?
Related Questions
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
Is there any benefit to checking serum viscosity in patients with autoimmune disease and headaches/migraines to see if aspirin or clopidogrel may be beneficial?
What clinical features help distinguish classical or vascular EDS from hypermobile EDS in patients presenting with joint hypermobility?
In a patient with SJIA who has been stable on Anakinra however is now planning to conceive or becomes pregnant, would you consider switching to Cimzia?
What is your approach to diagnosing and managing methotrexate-induced alopecia?
When would you consider use of emapalumab for HLH/MAS?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
How would you approach escalation of therapy in an adult patient with refractory Still’s disease and associated MAS/HLH (ferritin >100,000, transaminitis, DIC) despite high-dose steroids, high-dose anakinra, tocilizumab, and ruxolitinib?
What are your preferred alternative biologic agents for Blau Syndrome when anti-TNFα therapies are contraindicated?
What are useful clinical features that help differentiate mechanics hands from other conditions such as hand dermatitis or psoriasis?
